Fasting‑Induced Autophagy Optimized by Mitochondrial Uncoupling to Preserve Metabolic Rate and Extend Healthspan

Hypothesis

Prolonged fasting triggers autophagy but also suppresses resting metabolic rate (RMR), potentially limiting the healthspan benefits of cellular cleanup. We propose that mild mitochondrial uncoupling—achieved through low‑dose pharmacological agents such as 2,4‑dinitrophenol (DNP) analogues or endogenous fibroblast growth factor‑21 (FGF21) elevation—decouples ATP production from oxygen consumption, allowing cells to maintain a higher RMR while still experiencing the energetic stress that drives autophagy. In this state, autophagy is maximized because AMP‑activated protein kinase (AMPK) is activated by a rise in AMP/ATP ratio, yet the organism avoids the downstream transcriptional program that reduces RMR (e.g., reduced thyroid hormone signaling and leptin‑mediated thermogenesis) that typically accompanies caloric restriction. Consequently, the organism obtains the proteostatic advantages of autophagy without the metabolic down‑shift that predicts shorter lifespan in humans.

Mechanistic Rationale

1. Energetic signal integration – Autophagy initiation requires AMPK activation and inhibition of mTORC1. Fasting lowers intracellular ATP, raising AMP and activating AMPK. Mitochondrial uncoupling increases proton leak, further decreasing ATP synthesis efficiency, thereby amplifying the AMP/ATP signal without necessarily lowering nutrient‑sensing pathways that respond to caloric intake.
2. Preservation of RMR – Uncoupling increases oxygen consumption and heat production, counteracting the fasting‑induced drop in RMR. Human data show that a higher RMR correlates with shorter lifespan only when the elevation reflects pathological stress; a modest, controlled increase in uncoupling‑driven respiration may instead reflect a "metabolically resilient" state akin to the mice that lost least weight on CR.
3. Cross‑talk with FGF21 – Fasting raises hepatic FGF21, which promotes ketogenesis and insulin sensitivity. FGF21 also induces expression of uncoupling protein‑1 (UCP1) in beige adipocytes. By augmenting FGF21 signaling (e.g., via intermittent fasting cycles), we can boost uncoupling in adipose tissue, raising whole‑body RMR while preserving the autophagy‑promoting effects of fasting.

Testable Predictions

• Human trial design: Participants undergo a 5‑day fasting‑mimicking diet (FMD) either alone or combined with a low‑dose, FDA‑approved uncoupler (e.g., oral niclosamide ethanolamine at 10 mg/day). Primary outcomes: (a) lysosomal autophagy flux measured by circulating LC3‑II/I ratio and p62 degradation in peripheral blood mononuclear cells (PBMCs) before and after intervention; (b) 24‑hour resting energy expenditure (REE) via indirect calorimetry; (c) changes in serum FGF21 and thyroid hormones.
• Prediction 1: The fasting + uncoupler group will show a significantly greater increase in autophagy markers (≥30 % higher LC3‑II/I reduction) compared with fasting alone, despite no further decline (or a slight increase) in REE.
• Prediction 2: Serum FGF21 will rise proportionally to the uncoupler dose, correlating with both autophagy activation and maintained REE.
• Prediction 3: Participants exhibiting the highest autophagy flux without REE suppression will display the greatest improvement in insulin sensitivity (HOMA‑IR) and inflammatory markers (IL‑6, CRP) after a 4‑week follow‑up.

Falsifiability

If the uncoupler fails to augment autophagy markers beyond fasting alone, or if REE drops equivalently in both groups, the hypothesis is falsified. Likewise, a lack of correlation between FGF21 elevation and autophagy flux would refute the proposed mechanistic link.

Broader Implications

Demonstrating that autophagy can be potentiated without sacrificing metabolic rate would refine longevity protocols, shifting focus from maximal caloric suppression to metabolic resilience. This approach could be integrated with nutrient‑dense, protein‑modified diets to further inhibit mTORC1 via amino‑acid scarcity while preserving systemic energy turnover, addressing the current gap in human autophagy measurement during CR.

Key citations: fasting as autophagy inducer The effect of fasting or calorie restriction on autophagy induction; unknown optimal fasting duration in humans Could autophagy be the fast way to slowing neurodegenerative disease?; higher RMR correlates with shorter lifespan Raised basal metabolic rate correlates with reduced life expectancy in humans; CR reduces metabolic rate beyond weight loss Caloric restriction reduces metabolic rate beyond weight loss; renormalized mass-specific BMR predicts mortality Renormalized mass-specific basal metabolic rate declines with age; mice losing least weight on CR live longest Study probes how eating less can extend lifespan; CALERIE shows CR independent of weight loss Human CALERIE trials; nutrient‑dense CR enhances autophagy via TOR inhibition Nutrient-dense CR may enhance autophagy.